Author:
Solecki Lauriana,Loganadane Prisca,Gauthier Anne-Sophie,Simonin Manon,Puyraveau Marc,Delbosc Bernard,Saleh Maher
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Augood CA, Vingerling JR, de Jong PTVM, Chakravarthy U, Seland J, Soubrane G, et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol. 2006;124:529–35.
2. Friedman DS, O’Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PTVM, et al. Prevalence of age- related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–72.
3. Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106–e116.
4. Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640–2.
5. Chopra R, Wagner SK, Fasler K, Kortuem KU, Pontikos N, Afshar F, et al. Development of neovascular age-related macular degeneration in fellow eyes of patients undergoing intravitreal anti-VEGF therapy at a large tertiary ophthalmic hospital. Investig Ophthalmol Vis Sci. 2018;59:816–816.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献